Development of In Vitro Diagnostics for the Detection of SARS-CoV-2
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 75N93023C00024-0-9999-1
Grant search
Key facts
Disease
COVID-19, Disease XStart & end year
2023.02025.0Known Financial Commitments (USD)
$4,590,862Funder
National Institutes of Health (NIH)Principal Investigator
. SCOTT SCHAUSResearch Location
United States of AmericaLead Research Institution
SORRENTO THERAPEUTICS, INC.Research Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
To support the development of promising diagnostics technologies for biothreat pathogens and toxins, as well as pathogens causing emerging and reemerging infectious diseases. Areas of support may focus on improving performance of agnostic nucleic acid sequencing solutions on commercial platforms; methods that improve protein analyte detection; and efforts to improve direct-from-blood or other biofluid detection and identification of microbial infection.